FDA Inspection
Orion Corporation, Orion PharmaOrion Corporation, Orion Pharma – FDA Inspection, Sep 14, 2010
Record Details
This FDA Inspection record concerns Orion Corporation, Orion Pharma, with an inspection on September 14, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 14, 2010
- Product Type
- Drugs
View Company Profile
ID · b68c4db0-46a1-45de-bbb1-ff4c50f09529
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 680627
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Orion Corporation, Orion Pharma
8| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2024 | Not classified | Office of Inspections and Investigations | |
| June 2, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 21, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Orion Corporation, Orion Pharma
- FDA Inspection 1310408 - 2024-11-07
- FDA Inspection 1218973 - 2022-06-02
- FDA Inspection 1156118 - 2020-09-17
- FDA Inspection 1053840 - 2018-06-01
- FDA Inspection 1012832 - 2017-04-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.